Skip to main content
. 2017 Aug 19;313(6):H1109–H1118. doi: 10.1152/ajpheart.00153.2017

Fig. 9.

Fig. 9.

Chronic A61603 treatment reduced NAD(P)H oxidase 4 (NOX4). A: Western blot for detection of NOX4 in right ventricular homogenates. B: pooled data showing that NOX4 was lower in the bleomycin (Bleo) model with chronic A61603 treatment. *P < 0.05.